BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34592752)

  • 41. Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma.
    Mohammed Saleh MF; Kotb A; Abdallah GEM; Muhsen IN; El Fakih R; Aljurf M
    Curr Oncol; 2021 Dec; 28(6):5480-5498. PubMed ID: 34940095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Genetic alterations in new category of Peripheral T-cell lymphoma, not otherwise specified].
    Fukumoto K
    Rinsho Ketsueki; 2022; 63(12):1657-1667. PubMed ID: 36653140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic markers in peripheral T-cell lymphoma.
    Piccaluga PP; Agostinelli C; Gazzola A; Mannu C; Bacci F; Sabattini E; Pileri SA
    Curr Hematol Malig Rep; 2010 Oct; 5(4):222-8. PubMed ID: 20690003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
    Ondrejka SL; Grzywacz B; Bodo J; Makishima H; Polprasert C; Said JW; Przychodzen B; Maciejewski JP; Hsi ED
    Am J Surg Pathol; 2016 Mar; 40(3):335-41. PubMed ID: 26574844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.
    Manso R; González-Rincón J; Rodríguez-Justo M; Roncador G; Gómez S; Sánchez-Beato M; Piris MA; Rodríguez-Pinilla SM
    Oncotarget; 2018 Mar; 9(22):16124-16133. PubMed ID: 29662631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonal haematopoiesis: A common progenitor for cytotoxic peripheral T-cell lymphoma and angioimmunoblastic T-cell lymphoma.
    Vogelsberg A; Harland L; Borgmann V; Otto F; Weller JF; Nann D; Quintanilla-Martinez L; Fend F
    Br J Haematol; 2024 May; 204(5):2071-2076. PubMed ID: 38323682
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Moon CS; Reglero C; Cortes JR; Quinn SA; Alvarez S; Zhao J; Lin WW; Cooke AJ; Abate F; Soderquist CR; Fiñana C; Inghirami G; Campo E; Bhagat G; Rabadan R; Palomero T; Ferrando AA
    Nat Cancer; 2021 Jan; 2(1):98-113. PubMed ID: 33928261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
    Timmins MA; Wagner SD; Ahearne MJ
    Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.
    Agostinelli C; Piccaluga PP; Went P; Rossi M; Gazzola A; Righi S; Sista T; Campidelli C; Zinzani PL; Falini B; Pileri SA
    J Clin Pathol; 2008 Nov; 61(11):1160-7. PubMed ID: 18755717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
    Meeuwes FO; Brink M; Plattel W; Van der Poel MWM; Kersten MJ; Wondergem M; Böhmer L; Woei-A-Jin FJSH; Visser O; Oostvogels R; Jansen PM; Neelis KJ; Crijns APG; Daniëls LA; Snijders TJF; Vermaat JSP; Huls GA; Nijland M
    Haematologica; 2024 Apr; 109(4):1163-1170. PubMed ID: 37794805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.
    de Leval L; Rickman DS; Thielen C; Reynies Ad; Huang YL; Delsol G; Lamant L; Leroy K; Brière J; Molina T; Berger F; Gisselbrecht C; Xerri L; Gaulard P
    Blood; 2007 Jun; 109(11):4952-63. PubMed ID: 17284527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
    Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H
    Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Maura F; Dodero A; Carniti C; Bolli N; Magni M; Monti V; Cabras A; Leongamornlert D; Abascal F; Diamond B; Rodriguez-Martin B; Zamora J; Butler A; Martincorena I; Tubio JMC; Campbell PJ; Chiappella A; Pruneri G; Corradini P
    Haematologica; 2021 Nov; 106(11):2918-2926. PubMed ID: 33054126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential diagnosis and identification of prognostic markers for peripheral T-cell lymphoma subtypes based on flow cytometry immunophenotype profiles.
    Pu Q; Qiao J; Liu Y; Cao X; Tan R; Yan D; Wang X; Li J; Yue B
    Front Immunol; 2022; 13():1008695. PubMed ID: 36466894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral T-cell lymphoma with follicular T-cell markers.
    Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
    Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas.
    Huang Y; Moreau A; Dupuis J; Streubel B; Petit B; Le Gouill S; Martin-Garcia N; Copie-Bergman C; Gaillard F; Qubaja M; Fabiani B; Roncador G; Haioun C; Delfau-Larue MH; Marafioti T; Chott A; Gaulard P
    Am J Surg Pathol; 2009 May; 33(5):682-90. PubMed ID: 19295409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
    Maura F; Agnelli L; Leongamornlert D; Bolli N; Chan WC; Dodero A; Carniti C; Heavican TB; Pellegrinelli A; Pruneri G; Butler A; Bhosle SG; Chiappella A; Di Rocco A; Zinzani PL; Zaja F; Piva R; Inghirami G; Wang W; Palomero T; Iqbal J; Neri A; Campbell PJ; Corradini P
    Am J Hematol; 2019 Jun; 94(6):628-634. PubMed ID: 30829413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.